Pemoline
Back to searchMolecule Structure
Scientific Name
Pemoline
Description of the Drug
Pemoline is a central nervous system (CNS) stimulant that was previously used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01230
http://www.drugbank.ca/drugs/DB01230
Brand Name(s)
Cylert, Pemoline, Ronyl, Tradon, Volital
Company Owner(s)
Fosun Pharma Usa Inc, Watson Laboratories Inc, Abbott Laboratories Pharmaceutical Products Div, Actavis Elizabeth Llc, Mallinckrodt Inc, Teva Pharmaceuticals Usa, Vintage Pharmaceuticals Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| Atlas | pemoline | |
| SureChEMBL | SCHEMBL41636 | |
| PharmGKB | PA450836 | |
| Human Metabolome Database | HMDB0256214 | |
| DrugBank | DB01230 | |
| PubChem: Thomson Pharma | 15195094 | 14891808 |
| PubChem | 4723 | 137628477 |
| NMRShiftDB | 20201423 | |
| LINCS | LSM-5159 | |
| Nikkaji | J4.432F | |
| BindingDB | 50248019 | |
| EPA CompTox Dashboard | DTXSID3023427 | |
| DrugCentral | 2075 | |
| rxnorm | PEMOLINE | |
| KEGG Ligand | C07899 | |
| ChEBI | 7953 |
